Lonza builds new spray-drying facility in Oregon
The Bend site investment creates over 80 jobs and establishes Lonza as the leading US CDMO for commercial-scale spray-drying capacity by 2029.
See the latest news and media coverage for Lonza. We track all announcements, press releases, and industry mentions in real time, all in one place.
Dedicated CDMO serving the healthcare industry
lonza.comLast updated
In short: Lonza achieved strong H1 2026 growth, divested its capsules business for $3 billion, and expanded its U.S. spray-drying capacity.
The Bend site investment creates over 80 jobs and establishes Lonza as the leading US CDMO for commercial-scale spray-drying capacity by 2029.
Cimitan joins the Extended Executive Committee by January 2027 to unify global commercial strategy and customer engagement across the company.
Delivering non-GMP batches within ten days, RaMP helps scientists screen formulations quickly while aligning early work with future GMP manufacturing scalability.
The company upgraded its full-year margin outlook and saw double-digit growth across all platforms.
Lonza is launching the construction of a production site dedicated to spray drying in the United States. The plant, which will be erected in Bend, in the state...
Lonza significantly increases revenue and core EBITDA in the first half of the year, raises margin target range, and advances the sale of its capsule business.
The Lonza Group stock was slightly in the red on August 28, 2026, after the pharmaceutical supplier presented strong first-half figures for 2026 and appointed a new sales director. The Lonza Group...
Lonza's capsule division, which produces 260 billion capsules a year across ten sites, is going to the PE firm Lone Star Funds for about $3...
Track Lonza and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Lonza and other trending companies.